ALNYLAM PHARMACEUTICALS, INC.

ALNYNasdaq· Pharmaceutical Preparations

Price History

Revenue

$3.7B

▲ 65.2% YoY

Net Income

$313.7M

▲ 212.8% YoY

EPS

$2.33

▲ 206.9% YoY

Cash

$1.7B

▲ 71.5% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.